Number of items: 1.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. (2022)
Jonathan P Piccini,
Valeria Caso,
Stuart J Connolly,
Keith A A Fox,
Jonas Oldgren,
Schuyler Jones,
Diana Gorog,
Vaclav Durdil,
Thomas Viethen,
Christoph Neumann,
Hardi Mundl
and
Manesh R Patel
This list was generated on Sat Oct 24 02:12:15 2026 BST.